Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3406]
News [7763]
Articles [63]
Editorials [9]
Conferences [207]
elearning [49]
LUMINANCE: Results support use of durvalumab and platinum-etoposide for...
Dr Niels Reinmuth - University of Muenster, Gauting, Germany
LUMINANCE: Results support use of durvalumab and platinum-etoposide for extensive stage SCLC ( Dr Niels Reinmuth - University of Muenster, Gauting, Germany )
6 Apr 2023
CodeBreaK 200 shows sotorasib to be a more tolerable treatment option for...
Dr David Waterhouse - Dana-Farber Cancer Institute, Boston, USA
CodeBreaK 200 shows sotorasib to be a more tolerable treatment option for patients with pretreated, KRASG12C-mutated advanced NSCLC ( Dr David Waterhouse - Dana-Farber Cancer Institute, Boston, USA )
6 Apr 2023
Latest treatments in oesophageal cancer
Dr Costas Bizekis - NYU Langone Perlmutter Cancer Center, New York, USA
Latest treatments in oesophageal cancer ( Dr Costas Bizekis - NYU Langone Perlmutter Cancer Center, New York, USA )
5 Apr 2023
SOFT study: Clinical relevance of genomic alterations in premenopausal HR+...
Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia
SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer ( Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia )
28 Mar 2023
CG0070 plus pembro shows promising efficacy in NMIBC unresponsive to BCG
Dr Roger Li - Moffitt Cancer Center, Tampa, USA
CG0070 plus pembro shows promising efficacy in NMIBC unresponsive to BCG ( Dr Roger Li - Moffitt Cancer Center, Tampa, USA )
22 Mar 2023
African oncologists interaction with pharmaceutical industry
Prof Nazik Hammad - Queen's University, Kingston, Canada
African oncologists interaction with pharmaceutical industry ( Prof Nazik Hammad - Queen's University, Kingston, Canada )
22 Mar 2023
ASCO GU 2023: Prostate QoL data and apalutamide plus active surveillance
Prof Heather Payne and Dr Jochen Walz
ASCO GU 2023: Prostate QoL data and apalutamide plus active surveillance ( Prof Heather Payne and Dr Jochen Walz )
21 Mar 2023
Pembro monotherapy for participants with BCG–unresponsive HR NMIBC shows anti...
Prof Andrea Necchi - The Vita-Salute San Raffaele University, Milan, Italy
Pembro monotherapy for participants with BCG–unresponsive HR NMIBC shows anti-tumour activity ( Prof Andrea Necchi - The Vita-Salute San Raffaele University, Milan, Italy )
16 Mar 2023
Intravesical IO using durvalumab shows promising results for patients with high...
Dr Charalampos Fragkoulis - General Hospital of Athens, Athens, Greece
Intravesical IO using durvalumab shows promising results for patients with high risk NMIBC after BCG failure ( Dr Charalampos Fragkoulis - General Hospital of Athens, Athens, Greece )
16 Mar 2023
Choosing cancer medicines wisely in Africa
Dr Harrison Chuwa - The Aga Khan Hospital, Dar Es Salaam, Tanzania
Choosing cancer medicines wisely in Africa ( Dr Harrison Chuwa - The Aga Khan Hospital, Dar Es Salaam, Tanzania )
9 Mar 2023
Navigating evidence-based care with limited resources in Africa
Dr Verna Vanderpuye - National center for Radiotherapy and Nuclear Medicine...
Navigating evidence-based care with limited resources in Africa ( Dr Verna Vanderpuye - National center for Radiotherapy and Nuclear Medicine, Accra, Ghana )
9 Mar 2023
Pembrolizumab plus docetaxel used to treat patients with metastatic castration...
Prof Daniel Petrylak - Yale University Cancer Center, New Haven, USA
Pembrolizumab plus docetaxel used to treat patients with metastatic castration-resistant prostate cancer ( Prof Daniel Petrylak - Yale University Cancer Center, New Haven, USA )
6 Mar 2023

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation